The present invention relates to a fast dissolving tablet comprising a therapeutically effective amount of a phosphate binding polymer, such as sevelamer or pharmaceutically acceptable salt or derivative thereof, that exhibit limited swelling in the oral cavity, has pleasant taste and mouth feel, high phosphate binding capacity with fast binding kinetics and require limited amount of water intake.. A process for the preparation thereof is disclosed.

The invention relates to the preparation method of a solid pharmacotechnical form composed of a theurapetic drastic quantity of a phosphate-binding polymer and more precisely of sevelamer or of some pharmaceutically- accepted salts thereof in combination to colloidal silicon dioxide for improving the pharmacotechnical properties of the preparation.

598728 Disclosed is a sustained-release pharmaceutical dosage form adapted for oral administration to a subject in need thereof comprising a therapeutically effective amount of at least one bile acid sequestrant selected from colesevelam colesevelam hydrochloride and sevelamer a therapeutically effective amount of at least one proton pump inhibitor and a gastric-retention vehicle composition comprising one or more hydrogels wherein said dosage form is adapted for use in preventing or treating an...

The invention relates to a process of making polyallylamine with a reduced content of residual allylamine and, consequently, to the use of such product in making epichlorohydrin- crosslinked polyallylamine (a sevelamer polymer) of pharmaceutical quality.

The present invention relates to a process of separation of a crosslinked polyallylamine from allylamine and, consequently, to a process of determination of the content of the allylamine in the crosslinked polyallylamine.